Skip to main content

Instil Bio, Inc.

TIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001789769

No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Instil Bio, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of TIL: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders7779+2
Shares116.1M117.9M+1.87M (+1.6%)
Value$1.99B$1.27B−$717.9M (−36.2%)

New holders (12)

Institutions that held Instil Bio, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to TIL in Q1 2022
InstitutionSharesValue% of portfolio
Logos Global Management LP377,091$4.05M0.53%
Citadel Advisors LLC221,038$2.38M0.00%
Los Angeles Capital Management LLC42,460$456.0K0.00%
Tudor Investment Corp Et Al36,863$396.0K0.01%
Erste Asset Management GmbH27,500$320.9K0.01%
Quadrant Capital Group LLC26,905$289.0K0.03%
Truist Financial Corp13,464$145.0K0.00%
Barclays PLC8,779$95.0K0.00%
Amalgamated Bank7,576$81.0K0.00%
Amalgamated Financial Corp.7,576$81.0K0.00%
Tarbox Family Office, Inc.123$1.00K0.00%
Ellevest, Inc.4$00.00%

Sold out (10)

Institutions that held Instil Bio, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of TIL in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Avidity Partners Management LP408,140$6.98M
HighVista Strategies LLC56,901$974.0K
Parametrica Management Ltd50,699$867.0K
Rock Creek Group, LP34,795$404.0K
Wells Fargo & Company18,776$321.0K
Norges Bank15,000$257.0K
Gyon Technologies Capital Management, LP11,810$202.0K
SG Americas Securities, LLC8,871$152.0K
Migdal Insurance & Financial Holdings Ltd.923$15.0K
TCI Wealth Advisors, Inc.205$4.00K